FCH
RYTM icon

Freestone Capital Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

Freestone Capital Holdings’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Hold
3,700
– – 0.01% 424
2026
Q1 		$322K Hold
3,700
– – 0.01% 432
2025
Q4 		$396K Hold
3,700
– – 0.01% 379
2025
Q3 		$374K Hold
3,700
– – 0.01% 394
2025
Q2 		$234K Buy
+3,700
New +$227K 0.01% 404
2025
Q1 		– Sell
-3,700
Closed -$207K – 469
2024
Q4 		$207K Buy
+3,700
New +$204K 0.01% 419

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Freestone Capital Holdings's RYTM Position: Q2 2026 in Review

Freestone Capital Holdings held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 3,700 shares worth $411K. The position accounts for 0.01% of the portfolio, ranked #424.

Freestone Capital Holdings first reported a position in RYTM in Q4 2024 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Freestone Capital Holdings held 3,700 shares of Rhythm Pharmaceuticals worth $411K as of Q2 2026.
  • Freestone Capital Holdings left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.01% of Freestone Capital Holdings's portfolio in Q2 2026, its #424 holding.
  • Freestone Capital Holdings first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.